Johnson & Johnson

Drugs Industry Battered by Currency and Competition

US Court Orders J&J to pay $136 Million in Risperdal Case

Drug Majors’ Venture Capital Funds Back Genetics Start-up

J&J Buys License Option for Isis Pharma Bowel Drug

Express Scripts to Reimburse AbbVie Hepatitis C Drug

Bayer Said to Face US Litigation Over Xarelto Side Effects

Gordon Sangster to Join Codexis as Senior Vice President & CFO

Roche Alzheimer's Drug Fails Main Goals in Mid-stage Study

Roche to Buy US Biotech Firm Seragon for up to $1.7 Billion

Boehringer to Settle Lawsuits for $650 Million

International Drugmakers Meet Challenges

Bayer to Pay $14.2 Billion for U.S. Merck’s Consumer Business

Zimmer to Buy Biomet for $13.35 Billion

Carlyle See Buyout Firms Focus on Emerging Markets

Bayer Strikes Deal for Chinese Herbal Medicines Producer

Bayer, Novartis said to Eye Merck & Co consumer health unit

Drug Maker Boehringer Facing U.S. Lawsuits

Carlyle Wins J&J Diagnostic Unit

J&J Petitions FDA to Require ‘Similar’ Names For Biosimilars, Biologics

Carlyle Said Close to Buying J&J Diagnostics Unit

EU Fines Drugmakers €16 million for Painkiller Delay

J&J reaches $4 Billion Deal On Hip Implant Lawsuits

Jesse Wu Named Chairman of J&J China

Onyx Provides Drug Trial Data to Amgen, Other Potential Bidders

China Blocks GSK Finance Head From Leaving Country

European Medicines Agency Pave Way for Biosimilar Drug Breakthrough

Getting The Pulse

The Lion City - The Merlion - a mythical creature with the head of a lion and the body of a fish - is regarded as the Singapore icon ("Singapura" means "lion city" in Sanskrit). As one of the world's leading energy and chemical hubs, Singapore's contribution to the chemical industry is vast, both in terms of output and research.

Lundbeck, Merck KGaA and Others Fined for Blocking Rival Drugs

J&J in $1 Billion Deal to Bolster Prostate-Cancer Focus

After Tech Success, Israel Seeks Life Sciences Growth

EU to Fine Lundbeck, Others for Blocking Generic Drugs

New J&J Anti-depressant Related to "Special K" Party Drug

Drug Industry CEOs Plotting More Carve-outs

India Regulators Pull J&J Plant License on Baby Powder Concerns

Merck, Pfizer to Jointly Develop Diabetes Drug